What does CUSIP 63937X103 represent in this 13F holders report?

CUSIP 63937X103 is the security identifier for NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM used to aggregate holder disclosures.

How many institutions held NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in Q3 2013?

3 institutional investors reported NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM for Q3 2013. Use the holders table for investor-level position and value details.

NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class: Equity / COM
Total 13F shares: 43,350
Share change: +24,673
Total reported value: $115,000
Price per share: $2.67
Number of holders: 3
Value change: +$65,095
Number of buys: 2

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2013
Previous quarter: Q2 2013

Recent filing periods for CUSIP 63937X103:

Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q3 2013

As of 30 Sep 2013, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,350 shares. The largest 3 holders included Citadel Advisors LLC, WELLS FARGO & COMPANY/MN, and HUNTINGTON NATIONAL BANK. This page lists 3 institutional shareholders reporting positions in this security for the Q3 2013 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.